See also this year's filing and all EDGAR filings for this company.
PDF Report 0001583771_2018_Hepion_Pharmaceuticals_Inc.pdf
Logs
| info | NetIncome node detected by tax heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001583771')"} |
Graph
Absolute values for 0001583771, Hepion Pharmaceuticals Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 13,192,922 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 1,870,924 |
| 2 | PropertyPlantAndEquipmentNet | 67,564 |
| 3 | remainder_Assets | 3,253,182 |
| 4 | LiabilitiesCurrent | 2,944,874 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 6,381,851 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 7,371,885 |
| 9 | ResearchAndDevelopmentExpense | 13,651,987 |
| 10 | remainder_Expenses | -1,908,003 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 4,224,819 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 18,384,592 |
| 1 | Liabilities | 9,326,725 |
| 2 | Expenses | 19,115,869 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 9,057,867 |
| 5 | NetIncome | -14,891,050 |
| 6 | ComprehensiveNetIncome | -14,891,050 |
| 7 | BaseVar | 25,526,002 |
| 8 | EconomicCapitalRatio | 0.0497 |
Edgar->Model Mapping
Feature Distribution
Change over Time
